|
|
Volumn 66, Issue 17, 2009, Pages 1513-
|
|
FDA approves saxagliptin for type 2 diabetes
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
CYTOCHROME P450 3A4;
CYTOCHROME P450 3A5;
HEMOGLOBIN A1C;
INCRETIN;
INSULIN;
METFORMIN;
ONGLYZA;
SAXAGLIPTIN;
SULFONYLUREA;
UNCLASSIFIED DRUG;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG INDICATION;
DRUG LABELING;
FOOD AND DRUG ADMINISTRATION;
GLUCOSE BLOOD LEVEL;
HEADACHE;
HEMODIALYSIS;
HUMAN;
HYPOGLYCEMIA;
KIDNEY FUNCTION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
POSTPRANDIAL STATE;
PRIORITY JOURNAL;
TABLET;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
|
|
EID: 69749105421
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news090069 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|